This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant, awarded to Scorpido Photonics, aims to develop a novel optical method for the instant, non-invasive detection of microscopic tumors to enable more rapid and accurate point-of-care cancer diagnostics. The $274,990 award will fund the integration of plasmonic nanobubble sensors into a medical device platform and a standard-sized clinical endoscope for performing lung cancer diagnostic procedures. The key product is a flexible fiber optic probe that can be administered through an endoscope to noninvasively generate and detect plasmonic nanobubbles in tissue, enabling the instant direct detection of microscopic tumors. This technology seeks to supplement existing invasive surgical diagnostic procedures and capture a portion of the $25.5 billion annual cancer biopsy market. The project period runs from October 1, 2024 to September 30, 2025, and no sub-awards are planned.
Generated 2/25/25, 3:52 AM